Clinical Trials Directory

Trials / Sponsors / Instituto de Investigación Marqués de Valdecilla

Instituto de Investigación Marqués de Valdecilla

Academic / Other · 30 registered clinical trials7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingRandomized a Clinical Trial With Medical Device in Acute Ischemic Stroke
Acute Ischemic Stroke
N/A2025-10-01
RecruitingUtility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CI
Cirrhosis, Liver
2025-03-01
RecruitingEffectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Resi
Mild Cognitive Impairment
N/A2024-01-01
UnknownEvaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With
Patients With Nonalcoholic Steatohepatitis
Phase 22024-01-01
RecruitingPressure Injuries in the Operating Room and Their Perioperative Incidence in Patients Undergoing Neurosurgery.
PRESSURE INJURIES
2023-12-01
UnknownMepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.
Rhinosinusitis Chronic, Polyp, Nasal
Phase 42023-09-01
RecruitingOROPHARYNGEAL MYOFUNCTIONAL THERAPY IN OBSTRUCTIVE SLEEP APNEA
Obstructive Sleep Apnea
Phase 32023-05-01
UnknownBig Data Analysis of OSA Patients on Positive Airway Pressure (PAP) Treatment: Real-life Monitoring
Obstructive Sleep Apnea, Positive Airway Pressure
2022-07-01
UnknownTransdiagnostic Group Cognitive Behavioral Therapy (PsicAP-A) for Adolescents With Emotional Disorders
Emotional Disorder
N/A2022-04-01
RecruitingProphylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy
CMV
Phase 22022-03-26
WithdrawnEfficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dos
Covid19
Phase 32021-09-01
RecruitingA Population-based Cohort in Northern Spain
Chronic Disease
2021-04-20
TerminatedTO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
Arterial Hypertension, Sodium Urine, Primary Care Center
2020-09-01
CompletedPREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO
SARS-CoV-2 Infection (COVID-19)
Phase 32020-08-19
UnknownEfficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects
Non-alcoholic Steatohepatitis (NASH)
N/A2020-06-01
UnknownEffect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)
Rheumatoid Arthritis, Atherosclerosis
Phase 42020-04-30
UnknownObservational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectivenes
SARS-CoV-2
2020-04-22
WithdrawnRandomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With
COVID 19, Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Phase 42020-04-06
UnknownEndoscopic Bariatric Therapy in NASH Cirrhosis
Non-alcoholic Steatohepatitis (NASH)
2020-04-01
UnknownPortal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identificat
Fatty Liver Disease
2020-01-10
UnknownCost-effectiveness of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care
Emotional Disorder
N/A2020-01-01
UnknownDiagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
Non-alcoholic Fatty Liver Disease (NAFLD)
2019-09-30
UnknownA Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures
Hepatotropic Virus Infection, Addictive Behaviours o Conducts, Mental Disease
2019-05-10
UnknownImmunomediated Non-alcoholic SteaTohepatitis; Prevalence and Characterization. INSTInCT Study
Main Hypothesis is That in the NASH Associated to IMIDs, to Different Phenotypes co Exist
2019-01-07
UnknownMinimally Invasive Right Colectomy Anastomosis Study
Colorectal Cancer, Anastomotic Complication, Colectomy
2018-11-01
UnknownCognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)
Hepatitis C
Phase 42016-06-01
CompletedProgram of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAI
Hepatitis C
Phase 42016-05-10
UnknownSafety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
Cirrhosis and Coagulation
Phase 32016-05-01
UnknownEndothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.
Hepatitis C, Cardiovascular Diseases
Phase 42015-10-01
CompletedStudy to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)
Hepatitis C, Hepatitis B
2015-07-01